Peroxisome proliferator-activated receptors as sensors of fatty acids and derivatives

Cellular and Molecular Life Sciences

Volumn 64, Issue 19-20, 2007, Pages 2459-2464

  Grimaldi, P A ^a  

^a CENTRE DE BIOCHIMIE   (France)

Author keywords

Fatty acid; Metabolic syndrome; Obesity; PPAR; Type 2 diabetes

Indexed keywords

FATTY ACID; FATTY ACID DERIVATIVE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR;

CELL MATURATION; FAT BODY; GENE EXPRESSION; GENE FUNCTION; HUMAN; LIPID METABOLISM; METABOLIC SYNDROME X; MOLECULAR SENSOR; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PROTEIN BINDING; REVIEW; SKELETAL MUSCLE; TISSUE METABOLISM;

ANIMALS; FATTY ACIDS; HOMEOSTASIS; HUMANS; LIPID METABOLISM; LIPIDS; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS;

EID: 35648942191     PISSN: 1420682X     EISSN: 15691632     Source Type: Journal    
DOI: 10.1007/s00018-007-7278-5     Document Type: Review

References (50)

1. Issemann, I., Prince, R. A., Tugwood, J. D. and Green, S. (1993) The peroxisome proliferator-activated receptor: retinoid X receptor heterodimer is activated by fatty acids and fibrate hypolipidaemic drugs. J. Mol. Endocrinol. 11, 37-47.
2. Dreyer, C., Krey, G., Keller, H., Givel, F., Helftenbein, G. and Wahli, W. (1992) Control of the peroxisomal beta-oxidation pathway by a novel family of nuclear hormone receptors. Cell 68, 879-887.
3. Tontonoz, P., Hu, E., Graves, R. A., Budavari, A. I. and Spiegelman, B. M. (1994) mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer. Genes Dev. 8, 1224-1234.
4. Amri, E. Z., Bonino, F., Ailhaud, G., Abumrad, N. A. and Grimaldi, P. A. (1995) Cloning of a protein that mediates transcriptional effects of fatty acids in preadipocytes. Homology to peroxisome proliferator-activated receptors. J. Biol. Chem. 270, 2367-237.
5. Braissant, O., Foufelle, F., Scotto, C., Dauca, M. and Wahli, W. (1996) Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. Endocrinology 137, 354-366.
6. Nolte, R. T., Wisely, G. B., Westin, S., Cobb, J. E., Lambert, M. H., Kurokawa, R., Rosenfeld, M. G., Willson, T. M., Glass, C. K. and Milburn, M. V. (1998) Ligand binding and coactivator assembly of the peroxisome proliferator-activated receptor-gamma. Nature 395, 137-143.
7. Xu, H. E., Lambert, M. H., Montana, V. G., Parks, D. J., Blanchard, S. G., Brown, P. J., Sternbach, D. D., Lehmann, J. M., Wisely, G. B., Willson, T. M. et al. (1999) Molecular recognition of fatty acids by peroxisome proliferator-activated receptors. Mol. Cell 3, 397-403 .
8. Michalik, L. and Wahli, W. (1999) Peroxisome proliferator-activated receptors: three isotypes for amultitude of functions. Curr. Opin. Biotechnol. 10, 564-570.
9. Tontonoz, P., Hu, E., Devine, J., Beale, E. G. and Spiegelman, B. M. (1995) PPAR gamma 2 regulates adipose expression of the phosphoenolpyruvate carboxykinase gene. Mol. Cell. Biol. 15, 351-357.
10. Muoio, D. M., MacLean, P. S., Lang, D. B., Li, S., Houmand, J. A., Way, J. M., Winegar, D.A, Corton, J.C., Dohm, G.L. and Kraus, W.E. (2002) Fatty acid homeostasis and induction of lipid regulatory genes in skeletal muscles of peroxisome proliferator-activated receptor (PPAR) α knockout mice. Evidence for compensatory regulation by PPARδ. J. Biol. Chem. 277, 26089-26097.
11. Surapureddi, S., Yu, S., Bu, H., Hashimoto, T., Yeldandi, A. V., Kashireddy, P., Cherkaoui-Malki, M., Qi, C., Zhu, Y. J., Rao, M. S. et al. (2002) Identification of a transcriptionally active peroxisome proliferator-activated receptor alpha-interacting cofactor complex in rat liver and characterization of PRIC285 as a coactivator. Proc. Natl. Acad. Sci. USA 99, 11836-11841.
12. Dreyer, C., Keller, H., Mahfoudi, A., Laudet, V., Krey, G. and Wahli, W. (1993) Positive regulation of the peroxisomal beta-oxidation pathway by fatty acids through activation of peroxisome proliferator-activated receptors (PPAR). Biol. Cell 77, 67-76.
13. Grimaldi, P. A., Knobel, S. M., Whitesell, R. R. and Abumrad, N. A. (1992) Induction of aP2 gene expression by nonmetabolized long-chain fatty acids. Proc. Natl. Acad. Sci. USA 89, 10930-10934.
14. Forman, B. M., Tontonoz, P., Chen, J., Brun, R. P., Spiegelman, B. M. and Evans, R. M. (1995) 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Cell 83, 803-812.
15. Devchand, P. R., Keller, H., Peters, J. M., Vazquez, M., Gonzalez, F. J. and Wahli, W. (1996) The PPARalpha-leukotriene B4 pathway to inflammation control. Nature 384, 39-43.
16. Zomer, A. W., Van der Burg, B., Jansen, G. A., Wanders, R. J., Poll-The, B. T. and Van der Saag, P. T. (2000) Pristanic acid and phytanic acid: naturally occurring ligands for the nuclear receptor peroxisome proliferator-activated receptor alpha. J. Lipid Res. 41, 1801-1807.
17. Fu, J., Gaetani, S., Oveisi, F., Lo Verme, J., Serrano, A., Rodriguez De Fonseca, F., Rosengarth, A., Luecke, H., Di Giacomo, B. et al. (2003) Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha. Nature 425, 90-93.
18. Hertz, R., Berman, I., Keppler, D. and Bar-Tana, J. (1996) Activation of gene transcription by prostacyclin analogues is mediated by the peroxisome-proliferators-activated receptor (PPAR). Eur. J. Biochem. 235, 242-247.
19. Krey, G., Braissant, O., L'Horset, F., Kalkhoven, E., Perroud, M., Parker, M. G. and Wahli, W. (1997) Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay. Mol. Endocrinol. 11, 779-791.
20. Kliewer, S. A., Lenhard, J. M., Willson, T. M., Patel, I., Morris, D. C. and Lehmann, J. M. (1995) A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation. Cell 83, 813-819.
21. Kliewer, S. A., Sundseth, S. S., Jones, S. A., Brown, P. J., Wisely, G. B., Koble, C. S. et al. (1997) Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma. Proc. Natl. Acad. Sci. USA 94, 4318-4323.
22. Wolfrum, C., Borrmann, C. M., Bçrchers, T. and Spener, F. (2001) Fatty acids and hypolipidemic drugs regulate peroxisome proliferator-activated receptors alpha- and gamma-mediated gene expression via liver fatty acid binding protein: a signaling path to the nucleus. Proc. Natl. Acad. Sci. USA 98, 2323-2328.
23. Funk, C. D. (2001) Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 294, 1871-1875.
24. Brown, P. J., Stuart, L. W., Hurley, K. P., Lewis, M. C., Winegar, D. A., Wilson, J. G., Wilkison, W.O., Ittoop, O.R. and Willson, T.M. (2001) Identification of a subtype selective human PPARalpha agonist through parallel-array synthesis. Bioorg. Med. Chem. Lett. 11, 1225-1227.
25. Lehmann, J. M., Moore, L. B., Smith-Oliver, T. A., Wilkison, W. O., Willson, T. M. and Kliewer, S. A. (1995) An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). J. Biol. Chem. 270, 12953-12956.
26. Henke, B. R., Blanchard, S. G., Brackeen, M. F., Brown, K. K., Cobb, J. E., Collins, J. L., Harrington, W. W. Jr., Hashim, M. A., Hull-Ryde, E. A., Kaldor, I. et al. (1998) N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 1. Discovery of a novel series of potent antihyperglycemic and antihyperlipidemic agents. J. Med. Chem. 41, 5020-5036.
27. Berger, J., Leibowitz, M. D., Doebber, T. W., Elbrecht, A., Zhang, B., Zhou, G., Biswas, C., Cullinan, C. A., Hayes, N. S., Li, Y. et al. (1999) Novel peroxisome proliferator-activated receptor (PPAR) gamma and PPARdelta ligands produce distinct biological effects. J. Biol. Chem. 274, 6718-6725.
28. Sznaidman, M. L., Haffner, C. D., Maloney, P. R., Fivush, A., Chao, E., Goreham, D., Sierra, M.L., LeGrumelec C., Xu, H.E., Montana, V.G. et al. (2003) Novel selective small molecules agonists for peroxisome proliferator-activated receptor d (PPARd): synthesis and biological activity. Bioorg. Med. Chem. Lett. 13, 1517-1521.
29. Chakrabarti, R., Vikramadithyan, R. K., Misra, P., Hiriyan, J., Raichur, S., Damarla, R. K., Gershome, C., Suresh, J. and Rajagopalan, R. (2003) Ragaglitazar: a novel PPAR alpha PPAR gamma agonist with potent lipid-lowering and insulin-sensitizing efficacy in animal models. Br. J. Pharmacol. 140, 527-537.
30. Poirier, H., Niot, I., Monnot, M. C., Braissant, O., Meunier-Durmort, C., Costet, P., Pineau, T., Wahli, W., Willson, T. M. and Besnard, P. (2001) Differential involvement of peroxisome-proliferator-activated receptors alpha and delta in fibrate and fatty-acid-mediated inductions of the gene encoding liver fatty-acid-binding protein in the liver and the small intestine. Biochem. J. 355, 481-488.
31. Fasshauer, M. and Paschke, R. (2003) Regulation of adipocytokines and insulin resistance. Diabetologia 46, 1594-603.
32. Rosen, E. D., Walkey, C. J., Puigserver, P. and Spiegelman, B. M. (2000) Transcriptional regulation of adipogenesis. Genes Dev. 14, 1293-1307.
33. Kubota, N., Terauchi, Y., Miki, H., Tamemoto, H., Yamauchi, T., Komeda, K., Satoh, S., Nakano, R., Ishii, C., Sugiyama, T., Eto, K. et al. (1999) PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. Mol. Cell 4, 597-609.
34. Grimaldi, P. A. (2001) The roles of PPARs in adipocyte differentiation. Prog. Lipid Res. 40, 269-281.
35. Lemberger, T., Saladin, R., Vazquez, M., Assimacopoulos, F., Staels, B., Desvergne, B., Wahli, W. and Auwerx, J. (1996) Expression of the peroxisome proliferator-activated receptor alpha gene is stimulated by stress and follows a diurnal rhythm. J. Biol. Chem. 271, 1764-1769.
36. Holst, D., Luquet, S., Nogueira, V., Kristiansen, K., Leverve, X. and Grimaldi, P. A. (2003) Nutritional regulation and role of peroxisome proliferator-activated receptor delta in fatty acid catabolism in skeletal muscle. Biochim. Biophys. Acta 1633, 43-50.
37. Leone, T. C., Weinheimer, C. J. and Kelly, D. P. (1999) A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders. Proc. Natl. Acad. Sci. USA 96, 7473-7478.
38. Horowitz, J. F., Leone, T. C., Feng, W., Kelly, D. P. and Klein, S. (2000) Effect of endurance training on lipid metabolism in women: a potential role for PPARalpha in the metabolic response to training. Am. J. Physiol. Endocrinol. Metab. 279, E348-355.
39. Luquet, S., Lopez-Soriano, J., Holst, D., Fredenrich, A., Melki, J., Rassoulzadegan, M. and Grimaldi, P. A. (2003) Peroxisome proliferator-activated receptor delta controls muscle development and oxidative capability. FASEB J. 17, 2299-2301.
40. Wang, Y. X., Zhang, C. L., Yu, R. T., Cho, H. K., Nelson, M. C., Bayuga-Ocampo, C. R., Ham, J., Kang, H. and Evans RM. (2004) Regulation of muscle fiber type and running endurance by PPARd. PLOS Biol. 2, 1-8.
41. Barbier, O., Torra, J. P., Duguay, Y., Blanquart, C., Fruchart, J. C., Glineur, C., and Staels, B. (2002) Pleiotropic actions of peroxisome proliferator-activated receptors in lipid metabolism and atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 22, 716-726.
42. Vosper, H., Khoudoli, G. A., Graham, T. L. and Palmer, C. N. (2002) Peroxisome proliferator-activated receptor agonists, hyperlipidaemia, and atherosclerosis. Pharmacol. Ther. 95, 47-62.
43. Kadowaki, T., Hara, K., Yamauchi, T., Terauchi, Y., Tobe, K. and Nagai, R. (2003) Molecular mechanism of insulin resistance and obesity. Exp. Biol. Med. 228, 1111-1117.
44. Larsen, T. M., Toubro, S. and Astrup, A. (2003) PPARgamma agonists in the treatment of type II diabetes: is increased fatness commensurate with long-term efficacy? Int. J. Obes. Relat. Meta. Disord. 27, 147-161.
45. Tordjman, J., Chauvet, G., Quette, J., Beale, E. G., Forest, C. and Antoine, B. (2003) Thiazolidinediones block fatty acid release by inducing glyceroneogenesis in fat cells. J. Biol. Chem. 278, 18785-18790.
46. Guan, H. P., Li, Y., Jensen, M. V., Newgard, C. B., Steppan, C. M. and Lazar, M. A. (2002) A futile metabolic cycle activated in adipocytes by antidiabetic agents. Nat. Med. 8, 1122-1128.
47. Oliver, W. R., Shenk, J. L., Snaith, M. R., Russell, C. S., Plunket, K. D., Bodkin, N. L., Lewis, M.C., Winegar, D.A., Sznaidman, M.L., Lambert, M.H. et al. (2001) A selective peroxisome proliferator-activated receptor d agonist promotes reverse cholesterol transport. Proc. Natl. Acad. Sci. USA 98, 5306-5311.
48. Tanaka, T., Yamamoto, J., Iwasaki, S., Asaba, H., Hamura, H., Ikeda, Y. et al. (2003) Activation of peroxisome proliferator-activated receptor δ induces fatty acid b-oxidation in skeletal muscle and attenuates metabolic syndrome. Proc. Natl. Acad. Sci. USA 100, 15924-15929.
49. Daugaard, J. R. and Richter, E. A. (2001) Relationship between muscle fibre composition, glucose transporter protein 4 and exercise training: possible consequences in non-insulin-dependent diabetes mellitus. Acta Physiol. Scand. 171, 267-276.
50. Lam, T. K.T., Schwartz, G. J. and Rossetti, L. (2005) Hypothalamic sensing of fatty acids. Nat. Neurosci. 8, 579-584.